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C OVID-19 has led research institutions across the globe in a frenzied race to understand the virus, how it spreads, for whom it exacts its most devastating effects, which treatments work best, and how to best keep the general population safe.  However, 
wading through all the evidence around COVID is a daunting task even for 
the most experienced virologist, epidemiologist, or infectious disease 
physician. Separating good science from bad science also can be difficult. 
Thankfully, there are some tips and tricks for how critically appraise 
published research so you know how much weight to place on a particular 
study’s findings. Dr. Noah Zanville, Nurse Scientist for Miami Cancer 
Institute, discusses how the Evidence Pyramid can be used in appraise 
evidence on page 3.   
As you will see in his article, evaluating evidence starts with understanding 
what type of study is being described and its design. Randomized, controlled 
clinical trials (RCTs) are considered the gold-standard of treatment studies 
whereas systematic reviews/meta-analyses distill and clarify  findings 
from multiple studies so we can see the ‘big picture’ and make sure our 
conclusions still hold true. You may have noticed that during the first half of 
the pandemic, there were few RCTs and meta-analyses. Like all research, it 
takes time to design studies, develop protocols, write informed consents, 
design data collection forms, establish data safety and monitoring boards, 
obtain IRB approval, onboard sites, and conduct the study. Study conduct of 
course includes screening, recruiting, and enrolling patients, administering 
the study intervention, and obtaining follow-up data. Then the data need to 
be analyzed, visualized, interpreted, written up, submitted to a journal, 
undergo peer review, and if needed, revised again. Typically this whole 
process can take years to accomplish, but because of the urgency the 
pandemic, we have come to the publication of RCTs in less than a year.   
Typically, the final step in disseminating research findings is publishing 
findings in a peer-reviewed journal. The term ‘peer-review’ means that 
experts have had a chance to review (and critique) a manuscript before 
publication. When papers are published before peer-review on pre-print 
servers like MedRxive (pronounced ‘med-archive’), this review by experts 
has not yet happened. Early in the pandemic, it was imperative to share 
information as quickly as possible, with scientists and providers by 
publishing pre-prints, sometime multiple times a day in an effort to save lives, 
and for that, pre-publication servers were vital. 
As the pandemic continues on, so does the COVID-19 research even in our 
own health system. Take a look at some of the papers related to COVID-
19 that have been published by our physicians and staff, the most recent of 
which are included in the New Article Alcove on page 6. You also can search 
for COVID-19 in the Scholarly Commons which includes all publications and 
presentations as well as the nearly 50 Evidence Briefs prepared by the Nurse 
Scientists throughout the pandemic. 
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Spotlight on Boca Raton Regional Hospital's Research Programs 
LYNN CANCER INSTITUTE 
T 
he Office of Research Administration (ORA) at Boca Raton Regional Hospital 
provides support to the Lynn Cancer Institute (LCI) in conducting clinical trials for 
a wide spectrum of disease-specific areas, such as thoracic, breast, genitourinary, 
gastrointestinal, skin, and hematologic malignancies. For example, LCI is involved in a 
Genetic Registry study with City of Hope and has in development a Senior Adult Program 
aiming to provide services to our patients 70 years of age and older, in which research is 
a key component.  
Currently, LCI is one of the largest cancer centers in Florida, seeing over 3,500 new 
cancer patients per year. LCI’s cancer trial portfolio includes innovative therapies such as 
immunotherapies, chemotherapies, and new radiation treatments. Our research nurses 
and coordinators work with medical oncologists, radiation oncologists, surgical 
oncologists, pathologists, and radiologists to enroll patients and conduct the nearly 100 
open oncology trials at LCI.   
According to seer.cancer.gov, approximately 1.8 million people in the United States were 
predicted to be diagnosed with cancer in 2020. LCI’s research driven team of passionate 
experts work with federal agencies and pharmaceutical companies that share the same 
vision in seeing that number lowered in the imminent future.  —Stephanie A. Boodram, 
Research Data Analyst, ORA/LCI & Ileana Vargas, Regulatory Specialist, ORA/LCI 
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A 
lthough I would venture that all of us here at Baptist Health are comfortable with the concept of 
‘evidence’, often, I’m surprised when I work with staff to learn that the one of the most important tools for 
understanding the evidence – the hierarchy of evidence (sometimes called the evidence pyramid) – 
remains hidden under the sands of time. Because of this, this month, I thought it would be a good idea to talk 
about what the evidence hierarchy is and why it is important for all of us in healthcare research to understand.  
The evidence hierarchy is one of the more important ideas to emerge from the evidence-based medicine (EBM) 
movement in the last 30 years. The idea (typically represented by a ‘pyramid’ that ranks different types of 
research and evidence from best to worst) emerged from the growing understanding that some evidence is 
stronger, more trustworthy, more useful, and should be more influential in clinical practice, health policy, and 
research than others. This idea, which emerged following disasters such as the thalidomide tragedy† where 
interventions were given based on weak or incomplete evidence, drove patient, providers and researchers to 
push for stronger evidence, and with it, tools for defining what strong evidence was.  
The resulting hierarch (popularized through the evidence pyramid) now guides everything from how we design 
and perform research, search the literature, and report findings; it is a simple but effective tool you and your 
teams can use. But, what determines where a study is ranked on the evidence pyramid? Although the answer 
to this question has some twists and turns, there are a few basic criteria: 
 First, research that is listed higher on the evidence pyramid tends to include more rigorous study designs 
that include elements like randomization, blinding, and placebos. These elements help to protect the study 
against things like research bias, participant expectations, and other threats, are critical for separating fact 
from fiction. 
 Second, because studies that are too small can make it looks like a treatment is effective when it really isn’t, 
studies that are higher on the pyramid tend to be larger and have more representative samples. 
 Third, because even a fantastic study is still only just one study done in one sample and at one time point, 
when we are looking for strong evidence, typically we want to see the results of many studies. This idea 
(which lead to the development of systematic review and meta-analysis) helps clinicians, researchers and 
policy-makers see the ‘bigger picture’ so they can properly evaluate the science in particular area.  
In recent years, a lot of work has been done to help to refine the our understanding of evidence pyramid. For 
example, an RCT that was done really poorly might not actually be that helpful just because it’s an RCT, and so 
groups like GRADE now have systems that can help you and your teams rate your evidence just like the 
experts do. That said, the idea that some evidence is stronger than others holds true, and is an important 
concept that all researchers should be using. So, whether your team is getting ready to review the literature, 
evaluate a policy, or test an intervention, make sure you reach for the pinnacle of the research pyramid so you 
can get the strongest evidence possible!  
If you need help, don’t forget to reach out Library 
and Research Support staff at Baptist Health 
South Florida’s Center for Research, who can 
help you find high quality evidence, as well as 
the nurse scientist or clinical research 
administrator at your entity, who are 
doctoral-prepared researchers who are 
ready to help with you research needs.  
†Kim KH, Scialli AR (2011) 
Thalidomide: The tragedy of birth 
defects and the effective 
treatment of disease.  Toxicol Sci 
122(1):1-6. 
—Noah Zanville, Ph.D., BSN, BA, 
Nurse Scientist, Miami Cancer 
Institute 
THE EVIDENCE PYRAMID 
 
Reaching your Research Pinnacle 
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Class of 2020-2021 Research Projects 
BHSF PHARMACY RESIDENCY 
A 
 pharmacy residency commences after graduation from a College of Pharmacy 
and it is a training program in a defined area of pharmacy practice for licensed 
pharmacists. This additional training program can take place in a variety of 
settings, which include hospitals, community pharmacies, ambulatory settings, and 
others.  In general, residency is a full-time commitment that requires a minimum of 12 
months to complete. Postgraduate Year One (PGY1) Pharmacy Residencies provide 
the opportunity to accelerate professional growth beyond entry level through 
supervised practice in patient-centered care and pharmacy operational services. 
Postgraduate Year Two (PGY2) Pharmacy Residencies build upon the broad-based 
competencies achieved in a PGY1 residency and strengthen the resident’s ability to 
provide care in the most complex of cases in a specialized area of pharmacy.  
Here at Baptist Health, we have PGY2 residencies in the areas of ambulatory, 
cardiology, and oncology.  As part of the resident’s educational responsibilities, 
participation in evidence-based research is required to successfully complete 
the program. The list on the next page demonstrates the outstanding research 
projects conducted by this year’s pharmacy residents of 2020-2021.   
—Eduardo A. Guizan Corrales, Pharm.D., PGY2 Oncology Pharmacy Resident 
Image from McKesson.com 
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Baptist Hospital of Miami 
Postgraduate Year One residency 
Giselle Chahili Modification process for evaluating fall risk in adults: A pharmacy-resident-led quality improvement process 
Robyn Feldman Driving appropriate clinical use of albumin 5%: Protocol Implementation 
Nicole Tadros Optimizing vancomycin use in febrile neutropenia patients 
Frank Moreno Review of the management of antiplatelet related bleeds 
Postgraduate Year Two residency 
Elizabeth N. Osmon, 
Oncology 
Post-implementation of dental education for bone-modifying agents used for bone lesions from metastatic 
solid tumors and multiple myeloma 
Claudia Martin Diaz, 
Oncology 




Real-world survival outcomes of afatinib versus osimertinib in EGFR mutation-positive non-small cell lung 
cancer in the first-line setting  
Eduardo Guizan 
Corrales, Oncology 
Evaluation of real-world treatment patterns in patients with metastatic castrate-sensitive prostate cancer 
treated at a community cancer center 
Laura Neubauer, 
Cardiology 
Pharmacist role in the management of patients receiving triple antithrombotic therapy 
Tony Nguyen, Critical 
Care 
Evaluation of empiric antibiotic prescribing in critically ill patients in a community hospital 
Beatriz T. Jimenez 
Cadilla, Ambulatory 
Evaluating the impact of a pharmacist-led community care team on Medicare diabetes quality measures 
within a health-system clinically integrated network 
South Miami Hospital, Postgraduate Year One residency 
Yanelys Duarte Developing antimicrobial stewardship competencies for pharmacist across the health system 
Armando Mieres 
Efforts to reduce vancomycin utilization: An Implementation of a vancomycin bundle monitoring tool at a 
community hospital 
West Kendall Hospital, Postgraduate Year One residency 
Yaimiry Martinez Development and implementation of an opioid stewardship program in a community hospital 
Reynold Lopetegui 
Impact of the non-opioid alternative law on non-surgical opioid prescribing practices: A quality improvement 
evaluation in a community hospital 
Homestead Hospital, Postgraduate Year One residency 
Grether Hernandez 
Gama 
Impact of a pharmacist-driven methicillin-resistant staphylococcus aureus nasal swab protocol on the de-
escalation of empiric vancomycin in the setting of community acquired pneumonia 
Boca Raton Regional Hospital, Postgraduate Year One residency 
Nasim Farahani Impact of inaccurately reported penicillin allergy on surgical site infection rates 
Katerina Lambrinos 
Impact of pharmacist-led discharge counseling on medication communication related hospital consumer 
assessment of healthcare providers and systems (HCAHPS) scores 
Farah Asgar 
Evaluation of enhanced recovery after surgery (ERAS) protocol implementation in colorectal surgery and total 
knee replacement at a community teaching hospital 
Mackenzie O'Leary 
Comparison of Clinical Outcomes between Patients Receiving Proton Pump Inhibitors versus H2 Receptor 
Antagonists for Stress Ulcer Prophylaxis 
Class of 2020-2021 Research Projects 
BHSF PHARMACY RESIDENCY 
6 
Explore our new publications! 
New Article Alcove 
Backler C, Bruce SD Suarez L, Ginex PK (2020) Radiodermatitis: Clinical 
summary of the ONS Guidelines™ for cancer treatment-related radiodermatitis. 
Clin J Oncol 24(6): 1-4.   Find it here! 
Baralt M & Darcy Mahoney A (2020) Bilingualism and the executive function 
advantage in preterm-born children.  Cog Dev 55:100931.  Find it here! 
Cohen B, Cooley ME, Gray TF, ... Zanville N (2020) Nursing’s seat at the 
research roundtable. The Lancet, S0140-6736(20):32143-7.  Find it here! 
Darcy Mahoney A, White RD, Velasquez A, Barrett TS, Clark RH, Ahmad KA 
(2020) Impact of restrictions on parental presence in neonatal intensive care 
unites related to coronavirus disease 2019.  J Perinatol 40(Suppl 1):36-46.  Find 
it here! 
Franjul Sánchez A, Fuentes Armesto AM, Briones Chávez C, Ruiz M (2020) 
Revisiting early palliative are for patients with hematologic malignancies and 
bone marrow transplant: Why the delay? Cureus 12(9): e10504.  Find it here! 
Fridman S, Bres Bullrich M, Jiminez-Ruiz A, ... Vela-Duarte D, Linfante I, et al. 
(in press) Stroke risk, phenotypes, and death in COVID-19: Systematic review 
and newly reported cases.  Neurology Find it here! 
Gerhardt CA, Belzarena AC, Henderson-Jackson E, Mullinax JE, Joyce DM (2020) Intrapelvic melanocyte schwannoma 
resection with computer-assisted navigation.  Radiol Case Rep  15(11):2385-2390.  Find it here! 
Gosselin T, Ginex PK, Backler C, ... Suarez LV, et al. (2020) ONS Guidelines™ for Cancer Treatment–Related 
Radiodermatitis. Oncol Nurs Forum 47(6):654-670.  Find it here! 
Hosseinzadeh P, Mohseni M, Minaie A, Kiebzak GM (2020) 
Vitamin D status in children with forearm fractures: Incidence and 
risk factors.  J Am Acad Orthop Surg Glob Res Rev 4(8): e2000150-
5.  Find it here! 
Hull RA, Berger JM, Boster JM, Williams MU, Sharp AJ, Fentanes 
E, Maroules CD, Cury RC, Thomas DM (2020) Adoption of coronary 
artery disease—Reporting and Data System (CAD-RADS™) and 
observed impact on medical therapy and systolic blood pressure 
control.  J Cardiovasc Comput Tomogr 14(5):421-427.  Find it here! 
LeBlanc K, Dickens E, Gonzalez A, et al. (2020) Prospective, 
multicenter, pairwise analysis of robotic-assisted inguinal hernia 
repair with open and laparoscopic inguinal hernia repair: early 
results from the Prospective Hernia Study.  Hernia 24: 1069-1081.  
Find it here! 
McGranaghan P, Düngen HD, Saxena A, Rubens M, Salami J, 
..., Veledar E, et al. (2020) Incremental prognostic value of a 
novel metabolite-based biomarker score in congestive heart failure 
patients.  ESC Heart Fail 7(5): 3029-3039.  Find it here! 
Rubens M, Ramamoorthy V, Saxena A, McGranaghan P, Bhatt 
C, Das  S,  Shehadeh N, Veledar E, Viamonte-Ros A, Odia Y, 
Mehta MP, Kotecha R (in press) Inpatient palliative care use 
among critically ill brain metastasis patients in the United States.  
Am J Clin Oncol  Find it here! 
Storey S, Choee A, Von Ah D, Vachon E, Zanville N, Monahan PO, 
et al. (2020) Presence and distress of chemotherapy-induced 
peripheral neuropathy symptoms in upper extremities of younger 
and older breast cancer survivors.  J Pat Cent Res 7(4): 295-303.  
Find it here! 
 Photo by Henry Be on Unsplash 
Explore more publications from the 
Baptist Health Institutional Repository 
 
Center for Research 
 
Center for Advanced Analytics 
 
Miami Cancer Institute 
 
Miami Cardiac & Vascular Institute 
 
Miami Neuroscience Institute 
 
Miami Orthopedics & Sports 
Medicine Institute 
 
Did we miss your publication?  
Please send it to: 
library@baptisthealth.net 
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Mondays 12:00 to 1:30 pm 
Invite was sent out to Research Operations & 
Regulatory teams. Certificates provided. 
 
Because of the COVID-19 pandemic, we will be 
doing Zoom™ meetings only until further notice. 
 
Email Amy at amyst@baptisthealth.net if you 
are interested and did not receive an invite. 
Date Topic 
Monday, November 9th How to Conduct a Literature Search 
Monday, December 14th History of Informed Consent and HIPAA Authorization 
by Nursing & Clinical Research Organizations 
UPCOMING CONFERENCES 
MAGI West—November 2-12, 2020, San Francisco, CA  Virtual 
https://www.magiworld.org/EventInfo?EVT=49  
Onsemble—April 18-22, 2021, Phoenix, AZ 
https://onsemble.net/conference/ 
ACRP—May 14-17, 2021, Toronto, Canada 
https://acrpnet.org/event/acrp-2021-annual-conference/  
SOCRA—September 24-26, 2021, Denver, CO 
https://www.socra.org/annual-conference/future-annual-conference-dates/  
Nursing World Conference—October 18-21, 2021, Virtual 
https://nursingworldconference.com/  
ANCC Magnet & Pathway—November 11-13, 2021, Atlanta, GA  
https://www.magnetcon.org/ 
Photo by Ian Schneider on Unsplash  
The new list of dates and topics for 2021 will be  communicated in the January issue  as 
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The Center for Research would like to thank everyone who 
participated in the annual Clinical Conflict of Interest (CCOI) 
Disclosure period! Since July, our office received over 1,000 CCOI 
forms from individuals that participate in research across Baptist 
Health South Florida. This total includes CCOI forms from employed 
personnel via PeopleSoft and from non-employed personnel via the 
PDF version. We want to thank you for your compliance with 
completing this requirement and for your support reaching out to 
research personnel to facilitate its completion. Although the annual 
disclosure period has passed, our office continues to collaborate 
with groups and individuals to get all research personnel compliant 
and to provide compliance status upon requests. 
Please note that all research personnel are responsible for updating 
their CCOI form within 30 days of any event that leads to or creates 
an actual or potential Financial Conflict of Interest (FCOI) [e.g., 
acquiring a new significant financial interest (SFI), removal of/
change to an existing SFI] to ensure a timely 
disclosure. 
Do you have any questions or topics you would 
like for us to cover regarding conflicts of interest, 
compliance review, or billing compliance process? 
If so, contact us directly for all Research 
Compliance matters! 
Heather Osorio, Research Compliance & Billing 
Administrator, ResearchCompliance@baptisthealth.net   
Research Compliance Corner 
To contribute to this newsletter, please contact Dr. Amy Starosciak at amyst@baptisthealth.net or x79546. 
UPCOMING IRB DATES 
BHSF IRB 
Full Board Committee Meeting: Tuesday, November 24th  
Submission Deadline for October Meeting: Monday, November 16th 
MCI IRB 
Full Board Committee Meeting: Monday,  December 7th  
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